Dr. Adana A.M. Llanos is a cancer and molecular epidemiologist with training and expertise in population health and cancer health disparities research. She earned a Bachelor of Science in Biology (with a minor in Chemistry) from Howard University. She then earned a Doctor of Philosophy (PhD)in Genetics and Human Genetics, also from Howard University, completing her dissertation research in the Department of Oncology at Georgetown University Lombardi Comprehensive Cancer Center (LCCC) in the Division of Carcinogenesis, Biomarkers, and Epidemiology. Following the completion of her doctoral studies, she completed a 2-year post doctoral fellowship in a joint program of Carcinogenesis, Biomarkers and Epidemiology, and Minority Health and Health Disparities in the Department of Oncology at the LCCC. Following the fellowship at LCCC, she completed a 2-year post doctoral fellowship at the Ohio State University Comprehensive Cancer Center (OSUCCC),which focused on population health, health disparities, and molecular and cancer epidemiology. During her fellowship at the OSUCCC, she obtained a Master of Public Health (MPH) in Epidemiology from the Ohio State University College of Public Health.
Dr.Llanos has established a productive, collaborative research program that integrates molecular- and population-based studies, with the ultimate goal of addressing cancer outcomes inequities through collaborative research that centers on cancers that disproportionately affect minority and medically underserved populations. As recognition of cancer inequities has grown, efforts to move beyond simply documenting the issues and towards understanding causes and developing impactful interventions to address them have also grown. Her work in this topical area has contributed to an important national and international agenda. Given the expected growth in the incidence of cancer, population-based research offers important opportunities to improve public health, through developing and testing evidence-based strategies to promote improved cancer prevention and control, here in the United States and globally. This is an area that allows Dr. Llanos to leverage her doctoral degree in genetics, master’s degree in epidemiology, multidisciplinary postdoctoral training, and research experiences in cancer epidemiology, carcinogenesis, population sciences, and cancer prevention for the greatest impact. Her role as a public health scientist also involves public health advocacy. As such, it has been her goal and mission to advance public health science and human wellbeing – while contributing to the prevention of disease (particularly cancer) locally, nationally, and globally – through the conduct of rigorous, cutting-edge research and scholarship, engaging with the public, and advocating for policies, programs, and services with an emphasis on equity and social justice.
Dr.Llanos’ research contributions have been published in laudable scientific and biomedical journals, including: International Journal of Cancer; Cancer Epidemiology Biomarkers & Prevention; Carcinogenesis; Journal of Clinical Endocrinology and Metabolism; Cancer Causes and Control; and Epigenetics. In addition to teaching graduate courses in epidemiology, research, and scholarship activities, she is committed to providing professional service to the fields of cancer epidemiology and public health. In recognition of her research excellence she has been invited to serve as an ad hoc member of national and international grant review panels, including at the NIH, Susan G. Komen Foundation, and the French Institut National du Cancer (INCa – the French equivalent of the US NCI). Dr. Llanos is a member of the Editorial Board of Scientific Reports (Springer Nature journal) and BMC Women’s Health (Biomes-Central Series Journal).
Dr.Llanos is an active member of several national organizations, including the American Association for Cancer Research (AACR), American Society of Preventive Oncology (ASPO), and American Public Health Association (APHA), and the African Caribbean Cancer Consortium (AC3). She is also actively involved in community service through engagement with community-based organizations, particularly those whose mission includes providing timely public health advocacy, education and outreach, and cancer survivorship support among members of the community. She served for 2 years as a Board Member of the Yvonne McCalla Foundation, Inc.(YMF Inc. — a non-profit, community-based breast cancer organization. She currently serves on a National Community Advisory Board, led by Black Ladies Advocating for Cancer Care (BLACC) and the Stanford School of Medicine Office of Community Engagement (OCE). At the state-level, she serves as a Member of the Human Papillomavirus (HPV) in New Jersey Roundtable and Planning Committee with the New Jersey Chapter of the American Cancer Society and she previously served as a member of the Governor’s Public Outreach and Engagement Working Group for COVID-19Testing and Contact Tracing.
Click below to make an appointment. We will follow up to confirm your reservation.
Make an Appointment
